Wednesday, August 3, 2016 12:18 AM
FREMONT, Calif. and PADOVA, Italy—CenterVue
has received 510(k) clearance from the U.S. Food and Drug Administration
for fixation training for its MAIA platform, a technology designed to help patients rehabilitate from vision loss using audio feedback.
Wednesday, June 29, 2016 12:18 AM
BRUSSELS—Two optical technology companies are among the 15 finalists that have been shortlisted for the AAL Smart Ageing Challenge prize, which is offering €50,000 for the best innovation that uses the Internet of Things to empower older adults to achieve the quality of life they aspire to, socially and independently.
Friday, May 20, 2016 12:18 AM
recently welcomed state, city and county officials, business leaders and donors to its headquarters in downtown Wichita last week for the grand opening of the Gigi and Carl Allen Envision Research Institute (ERI).
Wednesday, November 18, 2015 12:24 AM
ST. PETERSBURG, Fla. and BARENDRECHT, The Netherlands—Freedom Scientific
have merged to create what they’re calling, “the world’s largest assistive technology provider for the visually impaired.”
Friday, August 7, 2015 12:15 AM
WICHITA, Kan.—Low vision advocacy organization, Envision
was given $75,000 from The Fidelity Bank Foundation. The money will go toward the completion of construction and the ongoing operation of the Envision Research Institute
, a facility being constructed within Envision’s headquarters here to serve as a hub of studies of the challenges associated with low vision and practical approaches to addressing them.
Monday, August 3, 2015 12:24 AM
, a low-vision advocacy organization, will hold a competition at its upcoming 2015 Conference
, to be held here Sept. 9 to 12, 2015, in which participants will vie for a grant of up to $10,000.
Friday, January 23, 2015 12:21 AM
DENVER—Low Vision organization,
, has announced that its 10th annual Envision Conference will be held Sept. 9 to 12, 2015, at the Grand Hyatt here.
Friday, January 16, 2015 12:15 AM
SYLMAR, Calif.—Health Canada has approved the
Argus II Retinal Prosthesis System
to treat individuals with severe to profound outer retinal degeneration, according to a statement released Jan. 12, 2015, from its developer,
Second Sight Medical Products, Inc.
(NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics to restore some functional vision to blind patients.
Wednesday, November 5, 2014 12:21 AM
VisionCare Ophthalmic Technologies
announced that the Centers for Medicare and Medicaid Services (CMS) will reimburse its Implantable Miniature Telescope under a revised Ambulatory Payment Classification designation, APC 0351, Level V Intraocular Procedures.
Friday, October 17, 2014 12:30 AM
VisionCare Ophthalmic Technologies
, a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration (AMD), announced earlier this month that the U.S. Food and Drug Administration approved the Implantable Miniature Telescope (by Dr. Isaac Lipshitz) for use in patients living with bilateral end-stage age-related macular degeneration who are age 65 or older.
Wednesday, July 30, 2014 12:18 AM
is inviting optical industry professionals to take part in the organization’s ninth annual
, a multidisciplinary low vision rehabilitation and research conference dedicated to improving the quality of low vision care through professional collaboration, advocacy, research and education.
Friday, July 11, 2014 12:30 AM
company that promotes advocacy and independence for those who are blind
or low vision, has named Gene Johnson vice president and general manager
of Envision Industries, its product manufacturing and assembly
Thursday, March 6, 2014 9:30 AM
WICHITA, Kan.—Blind and individuals with low vision joined with
professional musicians at a music workshop held here, Saturday Feb. 22.
Monday, February 17, 2014 12:30 AM
VISTA, Calif. And CONSHOHOCKEN, Pa.—The
Macula Vision Research Foundation
a unique partnership of industry and philanthropy to benefit more than
11 million people in the U.S. with age-related macular degeneration
(AMD) or other retinal related diseases.